HAL vs PTCT · P/E 9.3, $19.05B cap vs rev $806.8M
Halliburton Company (HAL) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported PTCT revenue for 2024-12-31 was $806.8M. Net income was -$363.3M. Revenue was down 14.0% from 2023-12-31 to 2024-12-31. PTCT currently screens at market cap $6.51B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the HAL and PTCT stock pages for the full models.
Not investment advice.